Cytek Biosciences Announces Preliminary Full Year 2023 Revenue Results

Go back to Cytek Biosciences Announces Preliminary Full Year 2023 Revenue Results
(NASDAQ: CTKB) Delayed: 5.65 -0.08 (1.4%)
Previous Close $5.73    52 Week High $ 
Open $5.71    52 Week Low $ 
Day High $5.75    P/E N/A 
Day Low $5.57    EPS $ 
Volume 1,494,813       

(NASDAQ: CTKB) Delayed: 5.65 -0.08 (1.4%)
Previous Close $5.73    52 Week High $ 
Open $5.71    52 Week Low $ 
Day High $5.75    P/E N/A 
Day Low $5.57    EPS $ 
Volume 1,494,813